42 filings
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Feb 24
Current report (foreign)
4:50pm
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Dec 23
Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma
6:10am
6-K
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
6-K
CNTB
Connect Biopharma Holdings Ltd
1 Nov 23
Current report (foreign)
3:57pm
6-K
CNTB
Connect Biopharma Holdings Ltd
20 Oct 23
Current report (foreign)
4:44pm
6-K
im9kvtiokxtnu
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
6-K
5yo0xqk4p7wd19
12 Sep 23
Current report (foreign)
6:13am
6-K
n5e8y
14 Jul 23
Current report (foreign)
5:00pm
6-K
ydqc1y4io
23 Jun 23
House Lease Contract
4:31pm
6-K
87o iwqn949h
5 Jun 23
Current report (foreign)
4:28pm
6-K
ja840ildb72ez3 8c0xv
1 Jun 23
Current report (foreign)
4:24pm
6-K
b9h krjm6zd6gl29
11 Apr 23
Connect Biopharma Reports Full Year 2022 Financial Results
5:00pm
6-K
7ngq0n9j9gk
21 Mar 23
Connect Biopharma CBP-201 Atopic Dermatitis Global Phase 2b Data Showed Rapid and Sustained Improvement Across all Body Regions
4:51pm
6-K
5kqefc9jkdvk
8 Feb 23
Connect Biopharma Reports CBP-201 Global Phase 2 Asthma Trial Achieves Full Enrollment
8:35pm
6-K
czdlbd7gl7zz6s
2 Feb 23
Current report (foreign)
7:01pm
6-K
zhutapi ppxwwbbwp9
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
6-K
z6r5 gzf1h6y9
2 Dec 22
Current report (foreign)
5:15pm
6-K
h3pcu
4 Oct 22
Current report (foreign)
7:16am
6-K
s78vc8w6zbj2x7w
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
6-K
jqe9mt
30 Aug 22
Current report (foreign)
4:01pm